LeMaitre Vascular, Inc. (LMAT) Q2 2019 Earnings Results

Lemaitre Vascular Inc. Beats on EPS, Stock Up 2.83%

The earnings report indicates that Lemaitre Vascular performed better than expected on EPS, which likely contributed to the positive stock reaction of 2.83%. However, the absence of revenue figures and guidance leaves some uncertainty about future performance. Investors may view the EPS beat as a positive sign, but the lack of additional financial metrics means they should remain cautious.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.23	N/A	+4.55%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding their current performance. They are focused on maintaining operational efficiency and driving innovation.

Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.

They emphasized their focus on operational efficiency and product innovation.

Lemaitre Vascular Inc. Beats on EPS, Stock Up 2.83%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Inc. Beats on EPS, Stock Up 2.83%

Key numbers

Management commentary